Sulochrin is a fungal metabolite isolated from both Penicillium sp. and Asperigillus, described to inhibit the degranulation, activation and chemotaxis of eosinophils. Additionally, Sulochrin has been shown to inhibit eosinophil O2 and IL-8 production, and LTC4 release. Studies suggest that Sulochrin inhibits the tube formation of HUVECs induced by the vascular endothelial growth factor (VEGF). Data from Aspergillus terreus lovastatin studies report Sulochrin as a co-metabolite during its fermentation.
1. Ohashi, H., et al. 1997. J. Antibiot. 50: 972-974. PMID: 9592574
2. Ohashi, H., et al. 1998. Inflamm. Res. 47: 409-415. PMID: 9831326
3. Ohashi, H., et al. 1999. Bioorg. Med. Chem. Lett. 9: 1945-1948. PMID: 10450959
4. Lee, H.J., et al. 2002. J. Antibiot. 55: 552-556. PMID: 12195960
5. Couch, R.D. and Gaucher, G.M. 2004. J. Biotechnol. 108: 171-178. PMID: 15129726
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.